Format

Send to

Choose Destination
Gastroenterol Clin North Am. 2014 Mar;43(1):1-14. doi: 10.1016/j.gtc.2013.11.006. Epub 2013 Dec 27.

Epidemiology of gastroesophageal reflux disease.

Author information

1
Veterans Affairs Center for Clinical Management Research, Ann Arbor, MI, USA; Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, USA. Electronic address: jhr@umich.edu.
2
Division of Gastroenterology, University of Michigan Medical School, Ann Arbor, MI, USA.

Abstract

The prevalence of gastroesophageal reflux disease (GERD) symptoms increased approximately 50% until the mid-1990s, when it plateaued. The incidence of complications related to GERD including hospitalization, esophageal strictures, esophageal adenocarcinoma, and mortality also increased during that time period, but the increase in esophageal adenocarcinoma has since slowed, and the incidence of strictures has decreased since the mid-1990s. GERD is responsible for the greatest direct costs in the United States of any gastrointestinal disease, and most of those expenditures are for pharmacotherapy. Risk factors for GERD include obesity, poor diet, lack of physical activity, consumption of tobacco and alcohol, and respiratory diseases.

KEYWORDS:

Cost; Esophageal neoplasms; Esophageal strictures; Incidence; Prevalence; Risk factors

PMID:
24503355
DOI:
10.1016/j.gtc.2013.11.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center